Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

NCT00620295 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma

Interventions

DRUG: bortezomib
DRUG: gemcitabine hydrochloride

Sponsor

Masonic Cancer Center, University of Minnesota